Patient characteristics in the entire study group Antonini-Canterin F, et al. Am J Cardiol 2008;102:738-42
Patient characteristics in the 3 subgroups of aortic valve disease severity Antonini-Canterin F, et al. Am J Cardiol 2008;102:738-42
Rate of disease progression, expressed as the rate of annual increase in Vmax (m/s/year) in the statin and nonstatin groups Antonini-Canterin F, et al. Am J Cardiol 2008;102:738-42
The change in aortic valve disease severity (at least 1 degree) during follow-up in the 3 subgroups Antonini-Canterin F, et al. Am J Cardiol 2008;102:738-42
Stepwise multiple linear regression analysis for the independent significant predictors of aortic valve disease progression Antonini-Canterin F, et al. Am J Cardiol 2008;102:738-42
Studies assessing the effects of statin therapy on the progression of AS Antonini-Canterin F, et al. Am J Cardiol 2008;102:738-42